[IOICORP] QoQ Quarter Result on 30-Sep-2014 [#1]

Stock
[IOICORP] IOI CORPORATION BHD
Announcement Date
17-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2015
Quarter
30-Sep-2014 [#1]
Profit Trend
QoQ- -56.64%
YoY- -41.45%
Quarter Report
Latest QR
Upcoming QR
IOICORP's Result
IOICORP's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 2,932,200 2,758,700 2,857,200 2,993,400 2,831,400 2,899,900 2,939,400 -0.16%
PBT 169,100 -109,200 94,600 268,300 433,000 460,000 487,300 -50.71%
Tax -60,400 -80,300 -69,000 -87,700 -30,300 1,725,100 7,000 -
NP 108,700 -189,500 25,600 180,600 402,700 2,185,100 494,300 -63.66%
-
NP to SH 112,700 -188,000 19,600 176,700 407,500 2,176,600 487,100 -62.41%
-
Tax Rate 35.72% - 72.94% 32.69% 7.00% -375.02% -1.44% -
Total Cost 2,823,500 2,948,200 2,831,600 2,812,800 2,428,700 714,800 2,445,100 10.09%
-
Net Worth 7,097,777 5,034,576 5,437,419 5,402,698 6,029,984 5,727,894 4,474,671 36.12%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 285,178 - 284,516 - 761,682 - 511,391 -32.32%
Div Payout % 253.04% - 1,451.61% - 186.92% - 104.99% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 7,097,777 5,034,576 5,437,419 5,402,698 6,029,984 5,727,894 4,474,671 36.12%
NOSH 6,337,301 6,372,881 6,322,580 6,356,115 6,347,351 6,364,327 6,392,388 -0.57%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 3.71% -6.87% 0.90% 6.03% 14.22% 75.35% 16.82% -
ROE 1.59% -3.73% 0.36% 3.27% 6.76% 38.00% 10.89% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 46.27 43.29 45.19 47.09 44.61 45.56 45.98 0.42%
EPS 1.78 -2.95 0.31 2.78 6.42 34.20 7.62 -62.17%
DPS 4.50 0.00 4.50 0.00 12.00 0.00 8.00 -31.92%
NAPS 1.12 0.79 0.86 0.85 0.95 0.90 0.70 36.91%
Adjusted Per Share Value based on latest NOSH - 6,356,115
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 46.85 44.08 45.66 47.83 45.24 46.34 46.97 -0.17%
EPS 1.80 -3.00 0.31 2.82 6.51 34.78 7.78 -62.41%
DPS 4.56 0.00 4.55 0.00 12.17 0.00 8.17 -32.28%
NAPS 1.1342 0.8045 0.8689 0.8633 0.9635 0.9153 0.715 36.13%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 4.06 4.59 4.80 4.81 5.25 4.80 4.71 -
P/RPS 8.77 10.60 10.62 10.21 11.77 10.53 10.24 -9.84%
P/EPS 228.30 -155.59 1,548.39 173.02 81.78 14.04 61.81 139.51%
EY 0.44 -0.64 0.06 0.58 1.22 7.13 1.62 -58.16%
DY 1.11 0.00 0.94 0.00 2.29 0.00 1.70 -24.79%
P/NAPS 3.63 5.81 5.58 5.66 5.53 5.33 6.73 -33.81%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 24/08/15 14/05/15 13/02/15 17/11/14 20/08/14 22/05/14 25/02/14 -
Price 3.93 4.21 4.81 4.70 5.00 5.19 4.73 -
P/RPS 8.49 9.73 10.64 9.98 11.21 11.39 10.29 -12.06%
P/EPS 220.99 -142.71 1,551.61 169.06 77.88 15.18 62.07 133.70%
EY 0.45 -0.70 0.06 0.59 1.28 6.59 1.61 -57.35%
DY 1.15 0.00 0.94 0.00 2.40 0.00 1.69 -22.69%
P/NAPS 3.51 5.33 5.59 5.53 5.26 5.77 6.76 -35.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment